General Shareholders‘ Meeting 2022
Dear Shareholders,
The General Shareholders’ Meeting of Epigenomics AG took place on June 15, 2022, as a virtual event without the physical presence of the shareholders in Munich. The presence amounted to around 33% of the share capital.
| Voting results of the Annual General Shareholders’ Meeting 2022 (German only) | |
| Invitation to the General Shareholders’ Meeting 2022 of Epigenomics AG | |
| Registration form | |
| Shareholder Portal | LINK |
| Curriculum vitae of Mr Heikki Lanckriet, Ph.D. | |
| Annual Report 2021 (incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report) |
|
| Financial Statements 2021 (German HGB) incl. key features of the internal control and risk management system (German only) |
|
| Agenda item 4: Remuneration system for members of the Executive Board | |
| Agenda item 5: Remuneration report 2021 | |
| Explanatory Report by the Management Board on Disclosures Pusuant to Section 289a (1), Section 315a (1) HGB (German only) | |
| Information pursuant to section 125 (2) of the German Stock Corporation Act (AktG) in conjunction with section 125 (5), Article 4 (1) and Table 3 of the Annex to the Commission Implementing Regulation (EU) 2018/1212 (EU-IR) (German only) | |
| Information on data protection |
Corporate Governance/Declaration of Governance
| 2021 | |
| Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) – October 2021 | |
| Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) |
Further information
| Explanation of Shareholders’ rights | |
| Articles of Association |